Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 326-334

  Hnatowich, D J ^a   Mardirossian, G ^a   Fogarasi, M ^a   Sano, T ^b   Smith, C L ^b   Cantor, C R ^b   Rusckowski, M ^a   Winnard Jr , P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOROTHIOIC ACID DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SINGLE STRANDED DNA; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG USE; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; BASE SEQUENCE; BIOTIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, SINGLE-STRANDED; ISOTOPE LABELING; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; ORGANOTECHNETIUM COMPOUNDS; THIONUCLEOTIDES; TISSUE DISTRIBUTION;

EID: 0029926891     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ABRAMS, M. J., JUWEID, M., TENKATE, C. I., SCHWARTZ, D. A., HAUSER, M. M., GAUL, F. E., FUCCELLO, A. J., RUBIN, R. H., STRAUSS, H. W., AND FISCHMAN. A. J.: Technetium-99m-human polyclonal IgG. radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31: 2022-2028, 1990.
2. AGARWAL, S AND GOODCHILD, J.: Oligodeoxynucleoside methylphosphates: synthesis and enzymatic degradation. Tetrahedron Lett. 28: 3539-3542, 1987.
3. AGRAWAL, S., TEMSAMANI, J., GALBRAITH, W , AND TANG, J.: Pharmacokinetics of antisense oligonucleotides Clin. Pharmacokinet. 28: 7-16, 1995.
4. AGRAWAL, S., TEMSAMANI, J. AND TANG, J Y : Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. U.S.A 88: 7595-7599, 1991.
5. BOS, E. B., KUIJPERS, W. H. A., MEESTERS-WINTERS, M. PHAM, D. T., DE HAAN, A. S., VAN DOORNMALEN, A. M., KASPERSEN, F. M., VAN BOECKEL, C A. A., AND GOUGEON-BERTRAND, F : In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res. 54: 3479-3486, 1994.
6. CAZENAVE, C., CHEVRIER, M., NGUGENT, T., AND HELENE, C.: Rate of degradation of alpha- and beta-oligodeoxynucleotides in xenopus oocytes. Implications for anti-messenger strategies Nucleic Acids Res. 15: 10507-10521, 1987.
7. CERUZZI, M. AND DRAPER, K.: The intracellular and extracellular fate of oligodeoxynucleotides in tissue culture systems Nucleosides Nucleotides 8: 815-818, 1989.
8. COSSUM, P. A., SASMOR, H., DELLINGER, D., TRUONG, L., CUMMINGS, L , OWENS, S. R , MARKHAM, P. M., SHEA, J. P., CROOKE, S.: Disposition of the 14C-labeled phosphorothioate oligonucleotide Isis 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267: 11810-1190, 1993.
9. DEWANJEE, M. K.: Radiolabeled antisense probes: Diagnosis and therapy. Diagn Oncol. 3: 189-208, 1993.
10. DEWANJEE, M K., GHAFOURIPOUR, A K. KAPAKVANJWALA, M., DEWANJEE, S., SERAFINI, A. N., LOPEZ, D. M., AND SFAKINAKIS, G. N : Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 35: 1054-1063, 1994.
11. GHOSH, M K., GHOSH, K. AND COHEN, J. S.: Phosphorothioate-phosphodiester oligonucleotide co-polymers: Assessment for antisense applications. Anticancer Drug Design 8: 15-31, 1993
12. GOODARZI, G., WATABE, M., AND WATABE, K.: Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice. Biopharm. Drug Dispos. 13: 221-227, 1992.
13. GOODCHILD, J.. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconj. Chem. 1: 165-187, 1990.
14. HNATOWICH, D. J., WINNARD, P. JR., FOGARASI, M., SANO, T., SMITH, C. L., CANTOR, C. R., RUSCKOWSKI, M.: Amplification of radioactivity using complementary DNA conjugates. In Proceedings in the Fifth Conference on Radioimmuno-detection and Radioimmunotherapy of Cancer, Princeton, NJ, 1994.
15. HNATOWICH, D. J., MARDIROSSIAN, G., RUSCKOWSKI, M., FOGARASI, M, VIRZI, F., AND WINNARD, P., JR.: Directly and indirectly technetium-99m-labeled antibodies-a comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34: 109-119, 1993.
16. HNATOWICH, D. J., WINNARD, P. JR., VIRZI, P., FOGARASI, M., SANO, T., SMITH, C. L., CANTOR, C. R , AND RUSCKOWSKI, M.: M. Labeling deoxyribonucleic acid oligonucleotides with 99mTc. J. Nucl. Med. (in press)
17. HOKE, G. D., DRAPER, K , FREIER, S. M., GONZALE, C., DRIVER, V. B., ZOUNES, M. C., AND ECKER, D. J.: Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res. 19: 5743-5748, 1991.
18. INAGAKI, M., TOGAWA, K., CARR, B. I., GHOSH, K. AND CHOEN, J. S.: Antisense oligonucleotides: inhibition of liver cell proliferation and in vivo disposition. Transplant. Proc 24: 2971-2972, 1992.
19. IVERSEN, P.: In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. Anticancer Drug Design 6: 531-538, 1991
20. LARSEN, S K., ABRAMS, M. J., HIGGINS, J. D., SOLOMON, H. F., BABICH, J. W., AND FISCHMAN, A. J.: Technetium complex of tricine: Useful precursor for the 99mTc labelling of hyrazino nicotinamide modified human polyclonal IgG (Abstract). J. Nucl. Med. 35: 105P, 1994.
21. 3H-labeled olignucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45: 932-943, 1994.
22. STEIN, C. A., SUBASINGHE, C., SHINOZUKA, K., SCHINOZUKA, K., AND COHEN, J. S.: Physiochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 16: 3209-3221, 1988.
23. TEMSAMANI, J., TANG, J. Y. AND, AGRAWAL S.: Capped oligodeoxynucleotide phosphorthioates: Pharmacokinetics and stability in mice. Antisense strategies. Ann. N.Y. Acad. Sci. 660: 318-329, 1992.
24. UHLMANN, E. AND PEYMAN, A.: Antisense oligonucleotides: A new therapeutic principle. Chem. Rev. 90: 543-584, 1990.
25. WETMUR, J. G.. DNA probes: Applications of the principles of nucleic acid hybridization Crit. Rev. Biochem. Mol Biol. 26: 227-259; 1991.
26. WICKSTROM, E.: Oligodeoxynucleotide stability in subcellular extracts and culture media. J Biochem. Biophys. Methods. 13: 97-102, 1986
27. ZENDEGUI, J. G., VASQUEZ, K. M., TINSLEY, J. H., KESSLER, D. J., AND HOGAN, M. E.: In vivo stability and kinetics of absorption and disposition of 3′ phosphopropyl amine oligonucleotides. Nucleic Acid Res. 20: 307-314, 1992.